The invention relates to the use of adenosine monophosphate deaminase 2 (AMPD2) inhibitors alone or in combination with various agents to treat a wide variety of diseases including, but not limited to, sugar craving, salt craving, umami craving, and addictions including drug, tobacco, nicotine and alcohol addictions. Embodiments of the invention may also relate to stimulation of AMPD2 activity to treat anorexia nervosa or stimulate food intake in a subject.
本发明涉及单
磷酸腺苷脱氨酶2(A
MPD2)
抑制剂单独使用或与各种制剂联合使用来治疗多种疾病,包括但不限于糖瘾、盐瘾、味觉瘾以及包括药物、烟草、
尼古丁和
酒精成瘾在内的成瘾。本发明的实施方案还可能涉及刺激 A
MPD2 的活性,以治疗神经性厌食症或刺激受试者的食物摄入量。